maklogo
Market Research Report

Global Implanted Stent Market Insights, Size, and Forecast By Type of Stents (Drug-Eluting Stents, Bare-Metal Stents, Bioresorbable Stents, Self-Expanding Stents), By End User (Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratories), By Application (Coronary Artery Disease, Peripheral Artery Disease, Carotid Artery Disease, Urology), By Material (Metallic Stents, Polymer Stents, Composite Stents, Biodegradable Stents), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Key Companies, Competitive Analysis, Trends, and Projections for 2026-2035

Report ID:39044
Published Date:Jan 2026
No. of Pages:232
Base Year for Estimate:2025
Format:
Customize Report

Key Market Insights

Global Implanted Stent Market is projected to grow from USD 17.8 Billion in 2025 to USD 29.3 Billion by 2035, reflecting a compound annual growth rate of 6.4% from 2026 through 2035. The implanted stent market encompasses a diverse range of medical devices designed to be inserted into bodily conduits or vessels to maintain patency, restore blood flow, or provide structural support. This critical market is primarily driven by the escalating global burden of cardiovascular diseases, particularly atherosclerosis, which necessitates interventional procedures like angioplasty and stenting. The aging global population, coupled with rising prevalence of lifestyle related diseases such as diabetes, obesity, and hypertension, further fuels the demand for implanted stents. Technological advancements, including the development of drug eluting stents DES with improved biocompatibility and reduced restenosis rates, as well as bioresorbable scaffolds BRS, represent a significant trend propelling market expansion. However, market growth is somewhat constrained by the high cost of advanced stent technologies and the potential for complications such as in stent thrombosis or restenosis. Emerging economies present substantial opportunities due to their expanding healthcare infrastructure, increasing disposable incomes, and growing awareness regarding minimally invasive treatment options.

Global Implanted Stent Market Value (USD Billion) Analysis, 2025-2035

maklogo
6.4%
CAGR from
2025 - 2035
Source:
www.makdatainsights.com

North America maintains its position as the dominant region in the implanted stent market. This leadership is attributed to well established healthcare systems, high adoption rates of advanced medical technologies, favorable reimbursement policies, and a significant prevalence of cardiovascular diseases requiring stent implantation. The presence of key market players and a robust research and development ecosystem also contribute to the region's strong market share. Conversely, Asia Pacific is emerging as the fastest growing region in the implanted stent market. This rapid growth is propelled by a large and aging population, increasing incidence of chronic diseases, improving access to healthcare services, and substantial investments in healthcare infrastructure development, particularly in countries like China and India. The rising awareness among patients and healthcare providers regarding advanced interventional therapies is also a key factor driving stent adoption in this region. Furthermore, the expanding medical tourism sector and a growing focus on preventive healthcare are contributing to the accelerated market expansion in Asia Pacific.

The market is segmented by Type of Stents, Application, Material, and End User, reflecting the diverse range of products and their utilization. The Coronary Artery Disease segment continues to be the leading application, underscoring the critical role of stents in managing ischemic heart conditions. Key players such as Medtronic, Abbott Vascular, Boston Scientific, and Johnson & Johnson are at the forefront of this competitive landscape. These companies are strategically focused on product innovation, particularly in developing next generation drug eluting stents and bioresorbable scaffolds, to improve patient outcomes and expand their market reach. Mergers and acquisitions, along with strategic collaborations, are common strategies employed by these industry leaders to consolidate market share, enhance technological capabilities, and penetrate new geographical markets. For instance, SIEMENS and Terumo Corporation are investing in R&D to develop advanced imaging techniques and stent delivery systems. Companies like Surmodics and Merit Medical Systems are concentrating on developing innovative coatings and peripheral stents, showcasing the diverse approaches to capturing market share within this dynamic and essential medical device sector.

Quick Stats

  • Market Size (2025):

    USD 17.8 Billion

  • Projected Market Size (2035):

    USD 29.3 Billion

  • Leading Segment:

    Coronary Artery Disease (68.4% Share)

  • Dominant Region (2025):

    North America (38.7% Share)

  • CAGR (2026-2035):

    6.4%

Global Implanted Stent Market Emerging Trends and Insights

Bioabsorbable Stents Poised for Dominance

Bioabsorbable stents are rapidly transforming the global implanted stent market. Unlike traditional metal stents that remain permanently, bioabsorbable alternatives gradually dissolve after serving their purpose of restoring blood flow and vessel structure. This inherent advantage eliminates long term complications associated with permanent implants, such as chronic inflammation, late stent thrombosis, and the need for prolonged antiplatelet therapy.

Their ability to disappear over time allows the natural healing process to restore vessel functionality more completely. This promotes improved vasomotion and reduces the risk of future interventions. Furthermore, bioabsorbable stents offer advantages for future diagnostic imaging as they do not interfere with scans like metal implants. As material science advances and clinical data solidify their efficacy and safety, bioabsorbable stents are becoming the preferred choice, positioned to dominate the implanted stent landscape.

AI Powered Stent Design and Personalized Medicine

AI is revolutionizing implanted stent design by enabling rapid iteration and optimization of biomechanical properties. Machine learning algorithms analyze vast datasets of patient anatomies, material science, and clinical outcomes to predict optimal stent configurations for individual patients. This personalized medicine approach goes beyond standard sizes and shapes, considering unique vessel geometries, blood flow dynamics, and specific disease characteristics. AI powered tools can simulate how different stent designs will perform within a patient's body, minimizing risks like restenosis or thrombosis. This leads to stents custom tailored for improved efficacy and longevity, moving away from a one size fits all paradigm towards precision healthcare solutions in the global implanted stent market.

Smart Stents Revolutionizing Patient Monitoring

Smart stents are transforming patient monitoring within the global implanted stent market. Traditionally, stents primarily offered mechanical support. Now, advanced smart stents integrate miniature sensors directly into their structure. These tiny biosensors continuously collect vital physiological data from within the patient's body, such as blood flow, pressure, and even early indicators of restenosis or other complications.

This real time, localized data is wirelessly transmitted to external devices, providing physicians with unprecedented insights into the stent’s performance and the patient's recovery. This proactive monitoring enables earlier detection of potential issues, allowing for timely interventions and personalized treatment adjustments. The trend reduces the need for frequent invasive follow up procedures, improves long term patient outcomes, and enhances overall quality of life, signifying a major shift towards more intelligent and connected healthcare solutions.

What are the Key Drivers Shaping the Global Implanted Stent Market

Rising Prevalence of Cardiovascular Diseases and Peripheral Artery Disease

The escalating global incidence of cardiovascular diseases and peripheral artery disease is a primary catalyst fueling the expansion of the implanted stent market. As populations age and lifestyles change, the prevalence of conditions like atherosclerosis, coronary artery disease, and peripheral artery obstructions continues to climb. These diseases often lead to narrowed or blocked blood vessels, severely impairing blood flow to vital organs and limbs. Implantation of stents becomes a crucial intervention to restore vascular patency, alleviating symptoms, preventing further complications like heart attacks, strokes, limb loss, and improving patient quality of life. The growing patient pool requiring such revascularization procedures directly translates to increased demand for various types of stents, including bare metal, drug eluting, and bioresorbable scaffolds across diverse anatomical locations. This persistent rise in diagnosed cases is a significant and sustained driver.

Advancements in Stent Technology and Minimally Invasive Procedures

Advancements in stent technology and minimally invasive procedures are significantly propelling the global implanted stent market. Innovations in material science have led to the development of more biocompatible and durable stents, reducing the risk of complications like restenosis and thrombosis. Drug eluting stents, for instance, continue to evolve with improved drug delivery mechanisms and polymer free designs, enhancing patient outcomes.

Simultaneously, the refinement of minimally invasive techniques, such as percutaneous coronary intervention and endovascular aneurysm repair, makes stent implantation safer and more accessible. These less invasive approaches offer reduced recovery times, lower infection rates, and less trauma for patients, encouraging broader adoption of stent therapies across various vascular applications. The continuous drive for less invasive and more effective treatment options fuels the demand for advanced stent technologies.

Expanding Geriatric Population and Growing Healthcare Expenditure

The escalating global geriatric population is a primary driver for the implanted stent market. As individuals age, the prevalence of cardiovascular diseases, peripheral artery disease, and other conditions requiring stent implantation significantly increases. This demographic shift naturally translates to a higher demand for these medical devices. Concurrently, a substantial rise in global healthcare expenditure further fuels market expansion. Governments and private entities are allocating more resources towards improving patient outcomes and expanding access to advanced medical treatments, including stent procedures. This increased investment facilitates greater adoption of innovative stent technologies and widens the patient base receiving these life saving interventions, directly contributing to the market's robust growth.

Global Implanted Stent Market Restraints

Stringent Regulatory Hurdles and Approval Timelines

The global implanted stent market faces significant challenges due to stringent regulatory hurdles and extended approval timelines. Innovations in stent design and materials, while promising for patient outcomes, must navigate complex and multi-stage approval processes enforced by health authorities worldwide. Each new product or significant modification requires extensive preclinical testing, rigorous clinical trials demonstrating safety and efficacy, and meticulous documentation to satisfy country-specific regulations. These demanding requirements often translate into years of development and review before a new stent can reach the market. This extended pathway not only inflates research and development costs for manufacturers but also delays patient access to potentially superior treatment options, effectively acting as a substantial barrier to market entry and rapid adoption of novel stent technologies.

High Product Cost and Limited Reimbursement

The global implanted stent market faces a significant challenge from high product costs. Developing cutting edge stents involves substantial research and development expenses, sophisticated manufacturing processes, and rigorous clinical trials, all contributing to high unit prices. This elevated cost becomes particularly problematic due to limited reimbursement policies from public and private payers worldwide. Many healthcare systems struggle to allocate sufficient funds to cover these expensive devices, especially in developing regions. Insurers often have stringent criteria for approving stent procedures and may only cover a portion of the cost or prefer less expensive alternatives. This creates a difficult situation for both manufacturers aiming to recoup their investments and patients needing access to life saving technology. The discrepancy between high costs and restricted reimbursement impedes market penetration and limits patient access globally.

Global Implanted Stent Market Opportunities

Growth Opportunities in Bioresorbable Stents for Cardiovascular and Peripheral Interventions

The global implanted stent market offers significant growth opportunities in bioresorbable stents for both cardiovascular and peripheral interventions. These advanced stents provide a temporary support structure, facilitating natural vessel healing before gradually dissolving, thereby potentially mitigating long term complications linked with permanent metallic implants. This inherent advantage drives increasing adoption among clinicians and patients seeking improved outcomes and reduced reintervention risks.

The Asia Pacific region emerges as a particularly high growth area. This surge is propelled by a rising prevalence of cardiovascular and peripheral artery diseases, alongside expanding healthcare access and technological advancements across its diverse economies. Innovators focusing on next generation bioresorbable materials and expanded clinical indications can capitalize on this evolving landscape. Continued research into enhanced biodegradation profiles and demonstration of robust long term efficacy will further accelerate market penetration, positioning bioresorbable stents as a cornerstone of future interventional therapies. This represents a prime area for strategic investment and market leadership.

Expanding Stent Applications: Addressing Unmet Needs in Peripheral Artery Disease and Non-Vascular Conditions

The global implanted stent market holds significant opportunity in broadening stent applications beyond traditional coronary uses. A major focus is addressing the substantial unmet needs within Peripheral Artery Disease PAD. This includes developing advanced stents specifically designed for challenging lower limb lesions, improving durability, and reducing restenosis rates where current solutions fall short.

Beyond vascular systems, a vast frontier exists in non vascular conditions. Stents can provide minimally invasive solutions for various luminal obstructions. This encompasses expanding applications in gastrointestinal strictures like esophageal or biliary blockages, respiratory tract stenosis such as tracheal or bronchial narrowing, and urological applications for ureteral strictures. Developing specialized stents for these areas, incorporating features like flexibility, biocompatibility, and drug elution, represents a powerful growth avenue. These innovations offer less invasive alternatives to surgery, improving quality of life for patients globally. This expansion into new anatomical sites and disease states drives market evolution and patient benefit.

Global Implanted Stent Market Segmentation Analysis

Key Market Segments

By Type of Stents

  • •Drug-Eluting Stents
  • •Bare-Metal Stents
  • •Bioresorbable Stents
  • •Self-Expanding Stents

By Application

  • •Coronary Artery Disease
  • •Peripheral Artery Disease
  • •Carotid Artery Disease
  • •Urology

By Material

  • •Metallic Stents
  • •Polymer Stents
  • •Composite Stents
  • •Biodegradable Stents

By End User

  • •Hospitals
  • •Ambulatory Surgical Centers
  • •Cardiac Catheterization Laboratories

Segment Share By Type of Stents

Share, By Type of Stents, 2025 (%)

  • Drug-Eluting Stents
  • Bare-Metal Stents
  • Bioresorbable Stents
  • Self-Expanding Stents
maklogo
$17.8BGlobal Market Size, 2025
Source:
www.makdatainsights.com

Why is Coronary Artery Disease dominating the Global Implanted Stent Market?

Coronary Artery Disease CAD commands the largest share due to its high global prevalence and critical nature, necessitating immediate and effective interventional treatments. Stents are a primary therapeutic option for opening blocked coronary arteries, improving blood flow, and preventing severe cardiac events. The well established treatment protocols and a large patient pool suffering from atherosclerosis contribute significantly to the widespread application of stents in CAD, making it the leading application segment by a substantial margin.

Which type of stent is most widely adopted and why?

Drug Eluting Stents are the prevailing choice within the By Type of Stents segment, primarily owing to their superior ability to prevent restenosis compared to Bare Metal Stents. These stents release medication that inhibits cell proliferation, significantly reducing the re narrowing of arteries and improving long term patient outcomes. While Bioresorbable and Self Expanding Stents offer specialized benefits, the proven efficacy and safety profile of Drug Eluting Stents have cemented their position as the preferred option for many cardiovascular interventions.

Where are implanted stents primarily utilized and why are certain settings crucial?

Hospitals represent the foremost end user segment for implanted stents. This dominance stems from their comprehensive facilities including advanced cardiac catheterization laboratories, availability of highly skilled cardiologists and surgical teams, and the capacity to manage complex procedures and immediate post operative care. While Ambulatory Surgical Centers and dedicated Cardiac Catheterization Laboratories also contribute, the integrated infrastructure and emergency support capabilities of hospitals make them indispensable for the majority of stent implantation procedures across various applications like Peripheral and Carotid Artery Disease.

Global Implanted Stent Market Regulatory and Policy Environment Analysis

The global implanted stent market operates within a highly scrutinized and fragmented regulatory framework. Rigorous premarket authorization is mandatory, with each major region maintaining distinct pathways. The United States Food and Drug Administration demands extensive clinical evidence, while Europe’s Medical Device Regulation mandates stringent conformity assessments via notified bodies, emphasizing safety and performance throughout the product lifecycle. Similar comprehensive approval processes exist in Asia Pacific nations, including China and Japan, often requiring localized data. Post market surveillance is increasingly critical across jurisdictions, tracking real world performance and adverse events. Reimbursement policies, driven by health technology assessments, significantly influence market access and adoption globally. Manufacturers must adhere to evolving quality management systems and international standards, navigating complex labeling requirements and data privacy regulations to ensure compliance and patient safety. Harmonization efforts aim to streamline some aspects, yet country specific nuances persist, shaping development and commercialization strategies.

Which Emerging Technologies Are Driving New Trends in the Market?

The implanted stent market is undergoing significant transformation, fueled by advancements in material science and smart technologies. Next generation drug eluting stents feature novel polymer coatings and advanced antiproliferative agents, enhancing efficacy and reducing restenosis rates. A major innovation is the rise of bioabsorbable stents, designed to degrade naturally after vessel healing, eliminating chronic foreign body presence and its associated risks. These evolving stents aim to improve long-term patient outcomes and minimize late complications.

Emerging technologies include smart stents integrated with sensors, enabling real time monitoring of blood flow, pressure, and potential blockages, offering early detection of issues like restenosis. Nanotechnology is being leveraged to create more biocompatible surfaces and precise drug delivery mechanisms, further personalizing treatment. Artificial intelligence and machine learning are optimizing stent design, placement accuracy, and predicting patient specific responses. Minimally invasive deployment techniques continue to refine, ensuring safer and more efficient procedures. These innovations are collectively driving market expansion and enhancing patient quality of life.

Global Implanted Stent Market Regional Analysis

Global Implanted Stent Market

Trends, by Region

Largest Market
Fastest Growing Market
maklogo
38.7%

North America Market
Revenue Share, 2025

Source:
www.makdatainsights.com

Dominant Region

North America · 38.7% share

North America stands as the dominant region in the global implanted stent market, capturing a significant 38.7% market share. This leadership is primarily driven by several key factors. The region boasts advanced healthcare infrastructure and high disposable incomes, enabling widespread access to sophisticated medical procedures. A high prevalence of cardiovascular diseases and peripheral artery disease further fuels demand for stents. Robust research and development activities, coupled with early adoption of innovative stent technologies, also contribute significantly to North America's preeminent position. Favorable reimbursement policies for cardiovascular interventions additionally incentivize the use of implanted stents across the United States and Canada.

Fastest Growing Region

Asia Pacific · 9.2% CAGR

Asia Pacific is poised to be the fastest growing region in the global implanted stent market, projected to expand at an impressive CAGR of 9.2% from 2026 to 2035. This remarkable growth is fueled by several converging factors. A rapidly aging population across countries like China and India significantly increases the prevalence of cardiovascular diseases, driving demand for stent implantation procedures. Furthermore improving healthcare infrastructure and expanding access to advanced medical treatments contribute to wider adoption of these life saving devices. Growing medical tourism in countries offering high quality and affordable healthcare further stimulates market expansion. Increased awareness about early disease detection and treatment alongside rising disposable incomes also empower more individuals to opt for necessary medical interventions involving implanted stents.

Impact of Geopolitical and Macroeconomic Factors

Geopolitical tensions, particularly involving major medical device manufacturing hubs in Asia and Europe, could disrupt supply chains for implanted stents. Trade disputes and export controls on critical raw materials or specialized components, often sourced from specific nations, present a significant risk. Political instability or regulatory shifts in key markets like China and India could impact market access and the speed of product adoption. Furthermore, intellectual property disputes between dominant players, often stemming from differing legal interpretations across jurisdictions, could impede innovation and market competition.

Macroeconomic factors significantly influence the market. Inflationary pressures on raw materials, energy, and labor costs increase manufacturing expenses, potentially leading to higher stent prices or reduced profitability. Healthcare budget constraints in various countries, exacerbated by economic downturns, can impact reimbursement policies and the overall volume of stent procedures. Currency fluctuations, particularly for companies with global operations, affect revenue streams and profitability when converting sales from international markets. Interest rate hikes could also increase borrowing costs for hospitals and device manufacturers, potentially slowing capital investments in healthcare infrastructure.

Recent Developments

  • March 2025

    Medtronic announced the acquisition of Novus Therapeutics, a privately held company specializing in bioresorbable stent technology for peripheral artery disease. This strategic move strengthens Medtronic's portfolio in the rapidly growing bioresorbable stent segment and expands its reach into new therapeutic areas.

  • June 2024

    Boston Scientific launched its next-generation self-expanding drug-eluting stent for the treatment of coronary artery disease, featuring an improved stent design and a novel polymer-free drug delivery system. This product aims to reduce long-term complications and improve clinical outcomes for patients.

  • October 2024

    Abbott Vascular entered into a research partnership with a leading artificial intelligence firm to develop AI-powered diagnostic tools for identifying patients at high risk of stent restenosis. This collaboration aims to personalize treatment strategies and improve patient monitoring post-stent implantation.

  • February 2025

    Terumo Corporation received FDA approval for its new generation of drug-coated balloon, designed for treating in-stent restenosis in peripheral arteries. This approval provides clinicians with another non-stent-based treatment option for a challenging patient population.

Key Players Analysis

Key players like Medtronic, Boston Scientific, and Abbott Vascular dominate the global implanted stent market. They leverage advanced technologies such as drug eluting stents and bioresorbable scaffolds. Strategic initiatives include extensive R&D, strategic acquisitions, and global expansion. These companies, alongside Siemens, Johnson & Johnson, and Terumo, are driving market growth through innovative product development, improved patient outcomes, and expanding applications in coronary, peripheral, and neurovascular interventions.

List of Key Companies:

  1. SIEMENS
  2. Johnson & Johnson
  3. Surmodics
  4. St Jude Medical
  5. Medtronic
  6. Abbott Vascular
  7. Merit Medical Systems
  8. Boston Scientific
  9. Terumo Corporation
  10. Cardinal Health
  11. Neovasc
  12. B. Braun Melsungen AG
  13. Royal Philips
  14. Cook Medical
  15. Abbott Laboratories
  16. Asian Medical Systems

Report Scope and Segmentation

Report ComponentDescription
Market Size (2025)USD 17.8 Billion
Forecast Value (2035)USD 29.3 Billion
CAGR (2026-2035)6.4%
Base Year2025
Historical Period2020-2025
Forecast Period2026-2035
Segments Covered
  • By Type of Stents:
    • •Drug-Eluting Stents
    • •Bare-Metal Stents
    • •Bioresorbable Stents
    • •Self-Expanding Stents
  • By Application:
    • •Coronary Artery Disease
    • •Peripheral Artery Disease
    • •Carotid Artery Disease
    • •Urology
  • By Material:
    • •Metallic Stents
    • •Polymer Stents
    • •Composite Stents
    • •Biodegradable Stents
  • By End User:
    • •Hospitals
    • •Ambulatory Surgical Centers
    • •Cardiac Catheterization Laboratories
Regional Analysis
  • North America
  • • United States
  • • Canada
  • Europe
  • • Germany
  • • France
  • • United Kingdom
  • • Spain
  • • Italy
  • • Russia
  • • Rest of Europe
  • Asia-Pacific
  • • China
  • • India
  • • Japan
  • • South Korea
  • • New Zealand
  • • Singapore
  • • Vietnam
  • • Indonesia
  • • Rest of Asia-Pacific
  • Latin America
  • • Brazil
  • • Mexico
  • • Rest of Latin America
  • Middle East and Africa
  • • South Africa
  • • Saudi Arabia
  • • UAE
  • • Rest of Middle East and Africa

Table of Contents:

1. Introduction
1.1. Objectives of Research
1.2. Market Definition
1.3. Market Scope
1.4. Research Methodology
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Market Factor Analysis
4.1. Porter's Five Forces Model Analysis
4.1.1. Rivalry among Existing Competitors
4.1.2. Bargaining Power of Buyers
4.1.3. Bargaining Power of Suppliers
4.1.4. Threat of Substitute Products or Services
4.1.5. Threat of New Entrants
4.2. PESTEL Analysis
4.2.1. Political Factors
4.2.2. Economic & Social Factors
4.2.3. Technological Factors
4.2.4. Environmental Factors
4.2.5. Legal Factors
4.3. Supply and Value Chain Assessment
4.4. Regulatory and Policy Environment Review
4.5. Market Investment Attractiveness Index
4.6. Technological Innovation and Advancement Review
4.7. Impact of Geopolitical and Macroeconomic Factors
4.8. Trade Dynamics: Import-Export Assessment (Where Applicable)
5. Global Implanted Stent Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
5.1. Market Analysis, Insights and Forecast, 2020-2035, By Type of Stents
5.1.1. Drug-Eluting Stents
5.1.2. Bare-Metal Stents
5.1.3. Bioresorbable Stents
5.1.4. Self-Expanding Stents
5.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
5.2.1. Coronary Artery Disease
5.2.2. Peripheral Artery Disease
5.2.3. Carotid Artery Disease
5.2.4. Urology
5.3. Market Analysis, Insights and Forecast, 2020-2035, By Material
5.3.1. Metallic Stents
5.3.2. Polymer Stents
5.3.3. Composite Stents
5.3.4. Biodegradable Stents
5.4. Market Analysis, Insights and Forecast, 2020-2035, By End User
5.4.1. Hospitals
5.4.2. Ambulatory Surgical Centers
5.4.3. Cardiac Catheterization Laboratories
5.5. Market Analysis, Insights and Forecast, 2020-2035, By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia-Pacific
5.5.4. Latin America
5.5.5. Middle East and Africa
6. North America Implanted Stent Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
6.1. Market Analysis, Insights and Forecast, 2020-2035, By Type of Stents
6.1.1. Drug-Eluting Stents
6.1.2. Bare-Metal Stents
6.1.3. Bioresorbable Stents
6.1.4. Self-Expanding Stents
6.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
6.2.1. Coronary Artery Disease
6.2.2. Peripheral Artery Disease
6.2.3. Carotid Artery Disease
6.2.4. Urology
6.3. Market Analysis, Insights and Forecast, 2020-2035, By Material
6.3.1. Metallic Stents
6.3.2. Polymer Stents
6.3.3. Composite Stents
6.3.4. Biodegradable Stents
6.4. Market Analysis, Insights and Forecast, 2020-2035, By End User
6.4.1. Hospitals
6.4.2. Ambulatory Surgical Centers
6.4.3. Cardiac Catheterization Laboratories
6.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
6.5.1. United States
6.5.2. Canada
7. Europe Implanted Stent Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
7.1. Market Analysis, Insights and Forecast, 2020-2035, By Type of Stents
7.1.1. Drug-Eluting Stents
7.1.2. Bare-Metal Stents
7.1.3. Bioresorbable Stents
7.1.4. Self-Expanding Stents
7.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
7.2.1. Coronary Artery Disease
7.2.2. Peripheral Artery Disease
7.2.3. Carotid Artery Disease
7.2.4. Urology
7.3. Market Analysis, Insights and Forecast, 2020-2035, By Material
7.3.1. Metallic Stents
7.3.2. Polymer Stents
7.3.3. Composite Stents
7.3.4. Biodegradable Stents
7.4. Market Analysis, Insights and Forecast, 2020-2035, By End User
7.4.1. Hospitals
7.4.2. Ambulatory Surgical Centers
7.4.3. Cardiac Catheterization Laboratories
7.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
7.5.1. Germany
7.5.2. France
7.5.3. United Kingdom
7.5.4. Spain
7.5.5. Italy
7.5.6. Russia
7.5.7. Rest of Europe
8. Asia-Pacific Implanted Stent Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
8.1. Market Analysis, Insights and Forecast, 2020-2035, By Type of Stents
8.1.1. Drug-Eluting Stents
8.1.2. Bare-Metal Stents
8.1.3. Bioresorbable Stents
8.1.4. Self-Expanding Stents
8.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
8.2.1. Coronary Artery Disease
8.2.2. Peripheral Artery Disease
8.2.3. Carotid Artery Disease
8.2.4. Urology
8.3. Market Analysis, Insights and Forecast, 2020-2035, By Material
8.3.1. Metallic Stents
8.3.2. Polymer Stents
8.3.3. Composite Stents
8.3.4. Biodegradable Stents
8.4. Market Analysis, Insights and Forecast, 2020-2035, By End User
8.4.1. Hospitals
8.4.2. Ambulatory Surgical Centers
8.4.3. Cardiac Catheterization Laboratories
8.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. South Korea
8.5.5. New Zealand
8.5.6. Singapore
8.5.7. Vietnam
8.5.8. Indonesia
8.5.9. Rest of Asia-Pacific
9. Latin America Implanted Stent Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
9.1. Market Analysis, Insights and Forecast, 2020-2035, By Type of Stents
9.1.1. Drug-Eluting Stents
9.1.2. Bare-Metal Stents
9.1.3. Bioresorbable Stents
9.1.4. Self-Expanding Stents
9.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
9.2.1. Coronary Artery Disease
9.2.2. Peripheral Artery Disease
9.2.3. Carotid Artery Disease
9.2.4. Urology
9.3. Market Analysis, Insights and Forecast, 2020-2035, By Material
9.3.1. Metallic Stents
9.3.2. Polymer Stents
9.3.3. Composite Stents
9.3.4. Biodegradable Stents
9.4. Market Analysis, Insights and Forecast, 2020-2035, By End User
9.4.1. Hospitals
9.4.2. Ambulatory Surgical Centers
9.4.3. Cardiac Catheterization Laboratories
9.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East and Africa Implanted Stent Market Analysis, Insights 2020 to 2025 and Forecast 2026-2035
10.1. Market Analysis, Insights and Forecast, 2020-2035, By Type of Stents
10.1.1. Drug-Eluting Stents
10.1.2. Bare-Metal Stents
10.1.3. Bioresorbable Stents
10.1.4. Self-Expanding Stents
10.2. Market Analysis, Insights and Forecast, 2020-2035, By Application
10.2.1. Coronary Artery Disease
10.2.2. Peripheral Artery Disease
10.2.3. Carotid Artery Disease
10.2.4. Urology
10.3. Market Analysis, Insights and Forecast, 2020-2035, By Material
10.3.1. Metallic Stents
10.3.2. Polymer Stents
10.3.3. Composite Stents
10.3.4. Biodegradable Stents
10.4. Market Analysis, Insights and Forecast, 2020-2035, By End User
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Cardiac Catheterization Laboratories
10.5. Market Analysis, Insights and Forecast, 2020-2035, By Country
10.5.1. South Africa
10.5.2. Saudi Arabia
10.5.3. UAE
10.5.4. Rest of Middle East and Africa
11. Competitive Analysis and Company Profiles
11.1. Market Share of Key Players
11.1.1. Global Company Market Share
11.1.2. Regional/Sub-Regional Company Market Share
11.2. Company Profiles
11.2.1. SIEMENS
11.2.1.1. Business Overview
11.2.1.2. Products Offering
11.2.1.3. Financial Insights (Based on Availability)
11.2.1.4. Company Market Share Analysis
11.2.1.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.1.6. Strategy
11.2.1.7. SWOT Analysis
11.2.2. Johnson & Johnson
11.2.2.1. Business Overview
11.2.2.2. Products Offering
11.2.2.3. Financial Insights (Based on Availability)
11.2.2.4. Company Market Share Analysis
11.2.2.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.2.6. Strategy
11.2.2.7. SWOT Analysis
11.2.3. Surmodics
11.2.3.1. Business Overview
11.2.3.2. Products Offering
11.2.3.3. Financial Insights (Based on Availability)
11.2.3.4. Company Market Share Analysis
11.2.3.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.3.6. Strategy
11.2.3.7. SWOT Analysis
11.2.4. St Jude Medical
11.2.4.1. Business Overview
11.2.4.2. Products Offering
11.2.4.3. Financial Insights (Based on Availability)
11.2.4.4. Company Market Share Analysis
11.2.4.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.4.6. Strategy
11.2.4.7. SWOT Analysis
11.2.5. Medtronic
11.2.5.1. Business Overview
11.2.5.2. Products Offering
11.2.5.3. Financial Insights (Based on Availability)
11.2.5.4. Company Market Share Analysis
11.2.5.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.5.6. Strategy
11.2.5.7. SWOT Analysis
11.2.6. Abbott Vascular
11.2.6.1. Business Overview
11.2.6.2. Products Offering
11.2.6.3. Financial Insights (Based on Availability)
11.2.6.4. Company Market Share Analysis
11.2.6.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.6.6. Strategy
11.2.6.7. SWOT Analysis
11.2.7. Merit Medical Systems
11.2.7.1. Business Overview
11.2.7.2. Products Offering
11.2.7.3. Financial Insights (Based on Availability)
11.2.7.4. Company Market Share Analysis
11.2.7.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.7.6. Strategy
11.2.7.7. SWOT Analysis
11.2.8. Boston Scientific
11.2.8.1. Business Overview
11.2.8.2. Products Offering
11.2.8.3. Financial Insights (Based on Availability)
11.2.8.4. Company Market Share Analysis
11.2.8.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.8.6. Strategy
11.2.8.7. SWOT Analysis
11.2.9. Terumo Corporation
11.2.9.1. Business Overview
11.2.9.2. Products Offering
11.2.9.3. Financial Insights (Based on Availability)
11.2.9.4. Company Market Share Analysis
11.2.9.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.9.6. Strategy
11.2.9.7. SWOT Analysis
11.2.10. Cardinal Health
11.2.10.1. Business Overview
11.2.10.2. Products Offering
11.2.10.3. Financial Insights (Based on Availability)
11.2.10.4. Company Market Share Analysis
11.2.10.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.10.6. Strategy
11.2.10.7. SWOT Analysis
11.2.11. Neovasc
11.2.11.1. Business Overview
11.2.11.2. Products Offering
11.2.11.3. Financial Insights (Based on Availability)
11.2.11.4. Company Market Share Analysis
11.2.11.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.11.6. Strategy
11.2.11.7. SWOT Analysis
11.2.12. B. Braun Melsungen AG
11.2.12.1. Business Overview
11.2.12.2. Products Offering
11.2.12.3. Financial Insights (Based on Availability)
11.2.12.4. Company Market Share Analysis
11.2.12.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.12.6. Strategy
11.2.12.7. SWOT Analysis
11.2.13. Royal Philips
11.2.13.1. Business Overview
11.2.13.2. Products Offering
11.2.13.3. Financial Insights (Based on Availability)
11.2.13.4. Company Market Share Analysis
11.2.13.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.13.6. Strategy
11.2.13.7. SWOT Analysis
11.2.14. Cook Medical
11.2.14.1. Business Overview
11.2.14.2. Products Offering
11.2.14.3. Financial Insights (Based on Availability)
11.2.14.4. Company Market Share Analysis
11.2.14.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.14.6. Strategy
11.2.14.7. SWOT Analysis
11.2.15. Abbott Laboratories
11.2.15.1. Business Overview
11.2.15.2. Products Offering
11.2.15.3. Financial Insights (Based on Availability)
11.2.15.4. Company Market Share Analysis
11.2.15.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.15.6. Strategy
11.2.15.7. SWOT Analysis
11.2.16. Asian Medical Systems
11.2.16.1. Business Overview
11.2.16.2. Products Offering
11.2.16.3. Financial Insights (Based on Availability)
11.2.16.4. Company Market Share Analysis
11.2.16.5. Recent Developments (Product Launch, Mergers and Acquisition, etc.)
11.2.16.6. Strategy
11.2.16.7. SWOT Analysis

List of Figures

List of Tables

Table 1: Global Implanted Stent Market Revenue (USD billion) Forecast, by Type of Stents, 2020-2035

Table 2: Global Implanted Stent Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 3: Global Implanted Stent Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 4: Global Implanted Stent Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 5: Global Implanted Stent Market Revenue (USD billion) Forecast, by Region, 2020-2035

Table 6: North America Implanted Stent Market Revenue (USD billion) Forecast, by Type of Stents, 2020-2035

Table 7: North America Implanted Stent Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 8: North America Implanted Stent Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 9: North America Implanted Stent Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 10: North America Implanted Stent Market Revenue (USD billion) Forecast, by Country, 2020-2035

Table 11: Europe Implanted Stent Market Revenue (USD billion) Forecast, by Type of Stents, 2020-2035

Table 12: Europe Implanted Stent Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 13: Europe Implanted Stent Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 14: Europe Implanted Stent Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 15: Europe Implanted Stent Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 16: Asia Pacific Implanted Stent Market Revenue (USD billion) Forecast, by Type of Stents, 2020-2035

Table 17: Asia Pacific Implanted Stent Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 18: Asia Pacific Implanted Stent Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 19: Asia Pacific Implanted Stent Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 20: Asia Pacific Implanted Stent Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 21: Latin America Implanted Stent Market Revenue (USD billion) Forecast, by Type of Stents, 2020-2035

Table 22: Latin America Implanted Stent Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 23: Latin America Implanted Stent Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 24: Latin America Implanted Stent Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 25: Latin America Implanted Stent Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Table 26: Middle East & Africa Implanted Stent Market Revenue (USD billion) Forecast, by Type of Stents, 2020-2035

Table 27: Middle East & Africa Implanted Stent Market Revenue (USD billion) Forecast, by Application, 2020-2035

Table 28: Middle East & Africa Implanted Stent Market Revenue (USD billion) Forecast, by Material, 2020-2035

Table 29: Middle East & Africa Implanted Stent Market Revenue (USD billion) Forecast, by End User, 2020-2035

Table 30: Middle East & Africa Implanted Stent Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2020-2035

Frequently Asked Questions

Industry

Healthcare Market Research

Explore comprehensive market research reports covering all aspects of the Healthcare industry, including market size, growth trends, competitive landscape, and strategic insights.

View Industry Page
;